BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 34521948)

  • 1. P16
    Ishikawa M; Nakayama K; Nakamura K; Yamashita H; Ishibashi T; Minamoto T; Sawada K; Yoshimura Y; Iida K; Razia S; Ishikawa N; Nakayama S; Otsuki Y; Kyo S
    Sci Rep; 2021 Sep; 11(1):18236. PubMed ID: 34521948
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Research on expression and importance of p53, p16 and VEGF-C in cervical cancer.
    Cai S; Han K
    J Gynecol Obstet Biol Reprod (Paris); 2015 Sep; 44(7):639-45. PubMed ID: 25443468
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of p16INK4a and pRb expression in cervical squamous and glandular neoplasia.
    Tringler B; Gup CJ; Singh M; Groshong S; Shroyer AL; Heinz DE; Shroyer KR
    Hum Pathol; 2004 Jun; 35(6):689-96. PubMed ID: 15188135
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Low P16
    Fu HC; Chuang IC; Yang YC; Chuang PC; Lin H; Ou YC; Chang Chien CC; Huang HS; Kang HY
    Int J Mol Sci; 2018 Aug; 19(9):. PubMed ID: 30150594
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HPV infection and p16
    Missaoui N; Mestiri S; Bdioui A; Zahmoul T; Hamchi H; Mokni M; Hmissa S
    Pathol Res Pract; 2018 Apr; 214(4):498-506. PubMed ID: 29572122
    [TBL] [Abstract][Full Text] [Related]  

  • 6. IMP3 is a novel biomarker for adenocarcinoma in situ of the uterine cervix: an immunohistochemical study in comparison with p16(INK4a) expression.
    Li C; Rock KL; Woda BA; Jiang Z; Fraire AE; Dresser K
    Mod Pathol; 2007 Feb; 20(2):242-7. PubMed ID: 17192788
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Downregulation of p16(ink4a) inhibits cell proliferation and induces G1 cell cycle arrest in cervical cancer cells.
    Zhang CY; Bao W; Wang LH
    Int J Mol Med; 2014 Jun; 33(6):1577-85. PubMed ID: 24714974
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Up-regulation of expression and lack of 5' CpG island hypermethylation of p16 INK4a in HPV-positive cervical carcinomas.
    Ivanova TA; Golovina DA; Zavalishina LE; Volgareva GM; Katargin AN; Andreeva YY; Frank GA; Kisseljov FL; Kisseljova NP
    BMC Cancer; 2007 Mar; 7():47. PubMed ID: 17359536
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunohistochemical overexpression of p16 protein associated with intact retinoblastoma protein expression in cervical cancer and cervical intraepithelial neoplasia.
    Sano T; Oyama T; Kashiwabara K; Fukuda T; Nakajima T
    Pathol Int; 1998 Aug; 48(8):580-5. PubMed ID: 9736404
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of p16(INK4A) but not hypoxia markers or poly adenosine diphosphate-ribose polymerase is associated with improved survival in patients with pancreatic adenocarcinoma.
    Chang DT; Chapman CH; Norton JA; Visser B; Fisher GA; Kunz P; Ford JM; Koong AC; Pai RK
    Cancer; 2010 Nov; 116(22):5179-87. PubMed ID: 20665497
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunohistochemical Expression of the Tumor Suppressor Protein p16INK4a in Cervical Adenocarcinoma.
    Eleutério J; Lima TS; Cunha MD; Cavalcante DI; Silva AM
    Rev Bras Ginecol Obstet; 2017 Jan; 39(1):21-25. PubMed ID: 28245508
    [No Abstract]   [Full Text] [Related]  

  • 12. Clinical and prognosis value of the CIMP status combined with MLH1 or p16
    Saadallah-Kallel A; Abdelmaksoud-Dammak R; Triki M; Charfi S; Khabir A; Sallemi-Boudawara T; Mokdad-Gargouri R
    Med Oncol; 2017 Aug; 34(8):147. PubMed ID: 28730335
    [TBL] [Abstract][Full Text] [Related]  

  • 13. P16(INK4a) protein expression in endocervical, endometrial and metastatic adenocarcinomas of extra-uterine origin: diagnostic and clinical considerations.
    Caponio MA; Addati T; Popescu O; Petroni S; Rubini V; Centrone M; Trojano G; Simone G
    Cancer Biomark; 2014; 14(2-3):169-75. PubMed ID: 24878818
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human papilloma virus early proteins E6 (HPV16/18-E6) and the cell cycle marker P16 (INK4a) are useful prognostic markers in uterine cervical carcinomas in Qassim Region--Saudi Arabia.
    Omran OM; AlSheeha M
    Pathol Oncol Res; 2015 Jan; 21(1):157-66. PubMed ID: 24925218
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic significance of cell cycle-associated proteins p16, pRB, cyclin D1 and p53 in resected oropharyngeal carcinoma.
    Plath M; Broglie MA; Förbs D; Stoeckli SJ; Jochum W
    J Otolaryngol Head Neck Surg; 2018 Sep; 47(1):53. PubMed ID: 30189895
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alterations of expression of Rb, p16(INK4A) and cyclin D1 in non-small cell lung carcinoma and their clinical significance.
    Brambilla E; Moro D; Gazzeri S; Brambilla C
    J Pathol; 1999 Aug; 188(4):351-60. PubMed ID: 10440744
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Different roles for p16(INK) (4a) -Rb pathway and INK4a/ARF methylation between adenocarcinomas of gastric cardia and distal stomach.
    Xue L; Ouyang Q; Li J; Meng X; Li Y; Xing L; Wang J; Yan X; Zhang X
    J Gastroenterol Hepatol; 2014; 29(7):1418-26. PubMed ID: 25123601
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The prognostic impact of cyclin dependent kinase inhibitors p21WAF1, p27Kip1, and p16INK4/MTS1 in adenocarcinomas of the uterine cervix: an immunohistochemical evaluation of expression patterns in population-based material from 142 patients with international federation of gynecology and obstetrics stage I and II adenocarcinoma.
    Alfsen GC; Reed W; Sandstad B; Kristensen GB; Abeler VM
    Cancer; 2003 Nov; 98(9):1880-9. PubMed ID: 14584070
    [TBL] [Abstract][Full Text] [Related]  

  • 19. p16 inactivation in small-sized lung adenocarcinoma: its association with poor prognosis.
    Kawabuchi B; Moriyama S; Hironaka M; Fujii T; Koike M; Moriyama H; Nishimura Y; Mizuno S; Fukayama M
    Int J Cancer; 1999 Feb; 84(1):49-53. PubMed ID: 9988232
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Correlation between p14(ARF)/p16(INK4A) expression and HPV infection in uterine cervical cancer.
    Kanao H; Enomoto T; Ueda Y; Fujita M; Nakashima R; Ueno Y; Miyatake T; Yoshizaki T; Buzard GS; Kimura T; Yoshino K; Murata Y
    Cancer Lett; 2004 Sep; 213(1):31-7. PubMed ID: 15312681
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.